Triple

T1136943
Position Surface form Disambiguated ID Type / Status
Subject Animal and Plant Health Inspection Service E23161 entity
Predicate hasDivision P35 FINISHED
Object Biotechnology Regulatory Services
Biotechnology Regulatory Services is a division of the U.S. Department of Agriculture that oversees the safe development, testing, and release of genetically engineered organisms in agriculture and the environment.
E130742 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Biotechnology Regulatory Services | Statement: [Animal and Plant Health Inspection Service, hasDivision, Biotechnology Regulatory Services]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Biotechnology Regulatory Services
Context triple: [Animal and Plant Health Inspection Service, hasDivision, Biotechnology Regulatory Services]
  • A. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • B. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • C. Lonza
    Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
  • D. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • E. Drug Discovery Unit
    The Drug Discovery Unit is a research center at the University of Dundee focused on translating basic biological research into new therapeutic candidates for diseases of global health importance.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Biotechnology Regulatory Services
Triple: [Animal and Plant Health Inspection Service, hasDivision, Biotechnology Regulatory Services]
Generated description
Biotechnology Regulatory Services is a division of the U.S. Department of Agriculture that oversees the safe development, testing, and release of genetically engineered organisms in agriculture and the environment.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Biotechnology Regulatory Services
Target entity description: Biotechnology Regulatory Services is a division of the U.S. Department of Agriculture that oversees the safe development, testing, and release of genetically engineered organisms in agriculture and the environment.
  • A. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • B. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • C. Lonza
    Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
  • D. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • E. Drug Discovery Unit
    The Drug Discovery Unit is a research center at the University of Dundee focused on translating basic biological research into new therapeutic candidates for diseases of global health importance.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493ec75988190b63a11bafaec29b4 completed March 1, 2026, 7:30 p.m.
NER Named-entity recognition batch_69a4bc2450c481909b9264e170070326 completed March 1, 2026, 10:22 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac59ae5f20819093f8acc3ba7a6638 completed March 7, 2026, 5 p.m.
NEDg Description generation batch_69ac5b5e2c688190a7d4998a3ed0f443 completed March 7, 2026, 5:07 p.m.
NED2 Entity disambiguation (via description) batch_69ac5bb6e78c8190a34ecbc246f72ff6 completed March 7, 2026, 5:09 p.m.
Created at: March 1, 2026, 7:44 p.m.